Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Aemetis Inc. anticipates significant revenue growth, projecting an increase from $398 million in 2025 to $1.8 billion by 2036, translating to an eleven-year compound annual growth rate (CAGR) of approximately 14.4%. The rebound of the company's operations in India and the potential financial benefits from its renewable natural gas (RNG) business, coupled with an anticipated initial public offering (IPO) for its biodiesel segment in 2025, could enhance its balance sheet considerably. Given these growth catalysts and solid operational execution, Aemetis is seen to have a favorable outlook despite early-stage financial challenges.

Bears say

Aemetis Inc reported a significant decline in revenue from its Indian operations, with Q4 revenues plummeting to $3 million from $32 million in Q3 2024. The company's fiscal Q4 2024 results revealed a net loss of $16.2 million, translating to a loss of $0.36 per share, which, while an improvement from the prior year's loss, still fell short of both estimates and consensus figures. This combination of declining revenue and continuing net losses raises concerns about the company's financial stability and operational performance, contributing to a negative outlook for its stock.

Aemetis (AMTX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Buy based on their latest research and market trends.

According to 8 analysts, Aemetis (AMTX) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.